{
    "nctId": "NCT01723423",
    "briefTitle": "Mastectomy Reconstruction Outcomes Consortium (MROC) Study",
    "officialTitle": "Mastectomy Reconstruction Outcomes Consortium (MROC) Study",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 4436,
    "primaryOutcomeMeasure": "Change from baseline in health-related quality of life.",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Women who present themselves for reconstruction at one of 11 MROC centers\n* Women undergoing one of the following types of breast reconstruction after mastectomy: tissue expander/implant, LD flap (with, or without implant), PTRAM flap, FTRAM flap, DIEP flap, S-GAP flap, I-GAP flap or SIEA flap.\n* Immediate or delayed reconstruction\n* Unilateral or bilateral reconstructions.\n* Women receiving mastectomy for cancer prophylaxis, without history of breast cancer, will be eligible to participate.\n\nExclusion Criteria:\n\n* Patients electing reconstruction following complications of breast augmentation, mastopexy (breast lift), or breast reduction will not be recruited for the study.\n* Procedures performed following previously failed attempts at breast reconstruction will be excluded from the study, due to potential confounding by these previous surgeries.",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}